1. Home
  2. IMCC vs ADXN Comparison

IMCC vs ADXN Comparison

Compare IMCC & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • ADXN
  • Stock Information
  • Founded
  • IMCC 1980
  • ADXN 2002
  • Country
  • IMCC Israel
  • ADXN Switzerland
  • Employees
  • IMCC N/A
  • ADXN N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMCC Health Care
  • ADXN Health Care
  • Exchange
  • IMCC Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • IMCC 8.0M
  • ADXN 8.9M
  • IPO Year
  • IMCC N/A
  • ADXN N/A
  • Fundamental
  • Price
  • IMCC $2.24
  • ADXN $8.10
  • Analyst Decision
  • IMCC
  • ADXN
  • Analyst Count
  • IMCC 0
  • ADXN 0
  • Target Price
  • IMCC N/A
  • ADXN N/A
  • AVG Volume (30 Days)
  • IMCC 27.6K
  • ADXN 2.1K
  • Earning Date
  • IMCC 08-12-2024
  • ADXN 08-08-2024
  • Dividend Yield
  • IMCC N/A
  • ADXN N/A
  • EPS Growth
  • IMCC N/A
  • ADXN N/A
  • EPS
  • IMCC N/A
  • ADXN N/A
  • Revenue
  • IMCC $54,143,148.00
  • ADXN $1,568,105.00
  • Revenue This Year
  • IMCC $11.51
  • ADXN N/A
  • Revenue Next Year
  • IMCC $19.17
  • ADXN N/A
  • P/E Ratio
  • IMCC N/A
  • ADXN N/A
  • Revenue Growth
  • IMCC 12.87
  • ADXN N/A
  • 52 Week Low
  • IMCC $1.13
  • ADXN $5.00
  • 52 Week High
  • IMCC $8.10
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 39.76
  • ADXN 41.47
  • Support Level
  • IMCC $1.80
  • ADXN $8.01
  • Resistance Level
  • IMCC $2.98
  • ADXN $8.30
  • Average True Range (ATR)
  • IMCC 0.32
  • ADXN 0.19
  • MACD
  • IMCC 0.02
  • ADXN 0.06
  • Stochastic Oscillator
  • IMCC 38.17
  • ADXN 22.16

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: